Emerging and re-emerging viruses

Emerging and re-emerging viruses

Closed
Course
en
English
24 h
This content is rated 0 out of 5
Source
  • From www.fun-mooc.fr
Conditions
  • Free Access
  • Free certificate
More info
  • 8 Sequences
  • Advanced Level
  • Starts on February 14, 2022
  • Ends on April 8, 2022

Their employees are learning daily with Edflex

  • Safran
  • Air France
  • TotalEnergies
  • Generali
Learn more

Course details

Syllabus

Chapter 1 – Introduction

  • W1-1: General Introduction
  • W1-2: Definition: Emerging and re-emerging
  • W1-3 : Principles : Vectors, Hosts, Reservoirs…
  • W1-4: One Health (Hervé Bourhy, Institut Pasteur)

Chapter 2 – Molecular mechanisms that drive viruses to be emerging or re-emerging

  • W2-1 : Newly identified viruses (Marc Eloit, Institut Pasteur)
  • W2-2 : Avian Influenza (Jean-Claude Manuguerra, Institut Pasteur)
  • W2-3: Previously known viruses that acquired additional virulence traits: Influenza viruses 1 and 2 (Sylvie van der Werf, Institut Pasteur)
  • W2-4: Control of the host on the virus (Carla Saleh, Institut Pasteur)

Chapter 3 – Conditions that favor emergence or re-emergence of viruses

  • W3-1: Changes in urbanization, human behavior (Pascal Handschumacher UNISTRA)
  • W3-2: Changes in Climate, deforestation, Natural disasters(Joacim Rocklöv (Université d’Umea, Sweden)
  • W3-3 : Coronavirus : SARS, MERS-CoV (Luis Enjuanes, Madrid)
  • W3-4: Yellow Fever(Nolween Jouvenet, Institut Pasteur)
  • W3-5: Hantavirus and Lassa Fever (Noel Tordo, Institut Pasteur)
  • W3-6: Human-nonhuman primate contact as a driver of viral emergence (Tamara Gilles-Vernick)
  • W3-7: A 20 year experience of Bluetongue circulation in Europe (Damien Vitour)

Chapter 4 – One health

  • W4-1: Bornavirus diseases (Hilde Angermeier, Institut Pasteur EUPHEM)
  • W4-2: Nipah Virus (Birgit Nikolai)
  • W4-3: Dengue (Marie Flamand, Institut Pasteur)
  • W4-4: Rift valley fever (Benjamin Brennan, Glascow)
  • W4-5: Crimean-Congo virus (Claudia Filippone, Institut Pasteur Madagascar)
  • W4-6: Hepatitis E (Nicole Pavio, ANSES Maisons-Alfort)

Chapter 5 : Epidemiology and Modelling

  • W5-1: Phylogeny and viruses (Noël Tordo, Institut Pasteur)
  • W5-2: Epidemiology of Zika (Arnaud Fontanet, Institut Pasteur)
  • W5-3: Epidemiology of Hepatitis C in Egypt (Arnaud Fontanet, Institut Pasteur)
  • W5-4: Ebola virus outbreak: From the field to the lab (Christophe Peyrefitte, Institut Pasteur Dakar)
  • W5-5: Quasispecies and viruses (Esteban Domingo, Madrid)
  • W5-6: Modelling the epidemiology of viral infection (Simon Cauchemez, Institut Pasteur)

Chapter 6 : Detection, Early management and infection control

  • W6-1 : Surveillance of vectors (Norbert Becker, Heidelberg)
  • W6-2 : Surveillance of viral diseases (Harold Noël, Santé Publique France)
  • W6-3 : Molecular epidemiology (Antoine Gessain, Institut Pasteur)
  • W6-4 : CIBU and Arboviruses (Jessica Vanhomwegen, Institut Pasteur)

Chapter 7 : Prevention and response

  • W7-1: Vector control activities (Norbert Becker, Heidelberg)
  • W7-2: Bioterrorism lessons from the past and Orthopoxvirus Antiviral strategy approach (Christophe Peyrefitte, Institut Pasteur Dakar)
  • W7-3: Preparedness (Marie-Paule Kieny, Inserm)
  • W7-4: Example: OITF of IP (Eileen Farnon/Amber Kunkel/Jean-Claude Manuguerra)
  • W7-5: Public health response: from science to politics (Didier Houssin, DGS)
  • W7-6: Vaccines (Frédéric Tangy, Institut Pasteur)
  • W7-7: Therapeutics (Etienne Decroly, AFMB Polytech, Luminy)
  • W7-8: WHO list of blueprint priority diseases (Marie-Paule Kieny, WHO)

Chapter 8 : Focus on SRAS-CoV2 - CoVid19

  • W8-1 : Covid19 - Virology (Olivier Schwartz)
  • W8-2 : Covid19 - Epidemiology (Arnaud Fontanet)
  • W8-3 : Covid19 - Vaccinology (Christiane Gerke)
  • W8-4 : Covid19 - Structure and Monoantibodies Therapy (Felix Rey)
  • W8-5 : Covid19 - Covid19 and its impact on the CNS (Hervé Bouhry ou/et Guilherme Dias De Melo)

 

 

Prerequisite

We recommend a good scientific background (such as a bachelor of life science)./ Un bon niveau scientifique est recommandé pour suivre ce MOOC (licence en sciences de la vie).

Instructors

Jean-Pierre Vartanian
Jean-Pierre Vartanian is Associate Professor at Institut Pasteur (Molecular Retrovirology Unit). He is the co-director of the Fundamental Virology course at the Institut Pasteur. His work is focused on identifying restriction factors involved in viral replication and the role of cellular RNA/DNA editing enzymes with antiviral activity against a range of human pathogens.

Pierre-Emmanuel Ceccaldi
Pierre-Emmanuel Ceccaldi is Professor at Université de Paris and Team Leader in the Epidemiology and Pathophysiology of Oncogenic Viruses Unit, Institut Pasteur. He is the co-director of the Fundamental Virology course at the Institut Pasteur. His work is focused on the interactions of different viruses with host barriers (blood-brain barrier, intestinal barrier…), and neuromuscular system.

Hilde Angermeier
Hilde Angermeier is a microbiologist and post-doctoral fellow within the European Public Health Microbiology training program (EUPHEM) of the European Centre for Disease Prevention and Control (ECDC). She is based for these two years at Institut Pasteur in Paris, France, where she is involved in different surveillance, public health microbiology research, laboratory and outbreak investigation, biorisk and quality management as well as teaching projects. Her ongoing projects involve the characterization of novel Yersinia species, seroprevalence studies on Hantaviruses and Leptospira, the genomic investigation of a recurrent Salmonella outbreak in France as well as the evaluation of the performance of rabies diagnostic tests in the frame of the quality management system present in the National Reference Center (NRC) for rabies. In addition, she has been involved in teaching during a workshop on rabies diagnostic techniques in Zimbabwe and in the development of massive open-online courses (MOOCs) of the Institut Pasteur.

Editor

The Institut Pasteur is a private, not-for-profit French foundation based in Paris, dedicated to the study of biology, micro-organisms, diseases and vaccines.

Created in 1888 thanks to an international public subscription, it is named after Louis Pasteur1, its founder and first director, who in 1885 developed the first vaccine against rabies.

For over a century, the Institut Pasteur has been at the forefront of the fight against infectious diseases. In 1983, this international research organisation was the first to isolate the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome (AIDS). Over the years, it has been responsible for revolutionary discoveries that have enabled medicine to control virulent diseases such as diphtheria, tetanus, tuberculosis, poliomyelitis, influenza, yellow fever, epidemic plague, hepatitis B and AIDS.

Platform

France Université Numérique is the broadcaster of the online courses of French higher education institutions and their partners.

It operates several platforms of diffusion, of which the best known, FUN MOOC, is the first French-speaking academic platform worldwide. Thanks to many partner institutions, this platform offers a vast catalog of courses enriched daily with various themes and current events.

Get certified in

‌
This content is rated 4.5 out of 5
(no review)
This content is rated 4.5 out of 5
(no review)
Complete this resource to write a review